Searchable abstracts of presentations at key conferences in endocrinology

ea0026p203 | Pituitary | ECE2011

Effects of dopamine agonist on heart and lung in patients receiving dopamine agonist due to hyperprolactinemia

Tacyildiz Cigdem , Dokmetas Hatice Sebila , Kilicli Fatih , Dogan Tamer , Arslanturk Hasan

Introduction: Dopamine agonists such as cabergoline and bromocriptine are used in the treatment of hyperprolactinemia to provide normoprolactinemia, to improve gonodal functions and to decrease the size of tumour if there is. Besides common side effects, fibrosis is another rare side effect of dopamine agonists. Long-term use of these drugs has been reported to cause fibrotic changes in heart valves. In addition, there are a few case reports about dopamine agonist-related pleu...